Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resistant Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05535192
What this trial is testing

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Who this might be right for
Breast CancerStage III Breast CancerBreast Cancer Female+2 more
Dana-Farber Cancer Institute 270
Not applicableNot Yet RecruitingNCT06595316
What this trial is testing

Exercise for Ameliorating Chemotherapy Cardiotoxicity

Who this might be right for
Cardiotoxicity
University of Hull 30
Not applicableStudy completedNCT05048108
What this trial is testing

Remote Assessment of Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers in Breast Cancer Survivors

Who this might be right for
Breast CancerObesity
Ohio State University Comprehensive Cancer Center 65
Testing effectiveness (Phase 2)UnknownNCT04780347
What this trial is testing

Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 92
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Not applicableEnded earlyNCT04436120
What this trial is testing

Treatment Resistance Following Anti-cancer Therapies

Who this might be right for
Disease Progression
Pfizer 38
Not applicableStudy completedNCT01106820
What this trial is testing

Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life

Who this might be right for
Breast CancerCancer-related Fatigue
German Cancer Research Center 101
Not applicableWithdrawnNCT00898573
What this trial is testing

Lapatinib Resistance in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Not applicableStudy completedNCT07338903
What this trial is testing

Feasibility and Effects of Home-based Physical Activity Intervention in Patients With Breast Cancer in Indonesia

Who this might be right for
Breast NeoplasmsPhysical Fitness
Gadjah Mada University 36
Not applicableUnknownNCT03979339
What this trial is testing

Feasibility of a New Technology for Isolating Circulating Tumour Cells

Who this might be right for
HER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more
Centre Oscar Lambret 76
Not applicableStudy completedNCT06016725
What this trial is testing

Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 75
Testing effectiveness (Phase 2)Looking for participantsNCT05076682
What this trial is testing

Reverse Triple Negative Immune Resistant Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Fudan University 80
Early research (Phase 1)Study completedNCT01884285
What this trial is testing

AZD8186 First Time In Patient Ascending Dose Study

Who this might be right for
Advanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer sqNSCLCTriple Negative Breast Cancer TNBC
AstraZeneca 147
Testing effectiveness (Phase 2)Study completedNCT01027208
What this trial is testing

A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline

Who this might be right for
Metastatic Breast Cancer
R-Pharm 20
Testing effectiveness (Phase 2)Looking for participantsNCT05601440
What this trial is testing

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Canadian Cancer Trials Group 484
Not applicableStudy completedNCT01621425
What this trial is testing

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

Who this might be right for
Breast CancerMetastatic Castration-resistant Prostate Carcinoma
Radboud University Medical Center 25
Post-approval studies (Phase 4)WithdrawnNCT04741204
What this trial is testing

Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer StageInsulin ResistanceRacial Bias
Woman's
Not applicableNot Yet RecruitingNCT07716306
What this trial is testing

Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer

Who this might be right for
Breast Cancer
Riga Stradins University 60
Early research (Phase 1)Active Not RecruitingNCT03162627
What this trial is testing

Selumetinib and Olaparib in Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastMalignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital Organs+2 more
M.D. Anderson Cancer Center 90
Next Page